[go: up one dir, main page]

GB2479294B - Method, composition and device for the treatment of enzymes and saccharides disorders - Google Patents

Method, composition and device for the treatment of enzymes and saccharides disorders

Info

Publication number
GB2479294B
GB2479294B GB1111470.9A GB201111470A GB2479294B GB 2479294 B GB2479294 B GB 2479294B GB 201111470 A GB201111470 A GB 201111470A GB 2479294 B GB2479294 B GB 2479294B
Authority
GB
United Kingdom
Prior art keywords
saccharides
disorders
enzymes
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB1111470.9A
Other versions
GB201111470D0 (en
GB2479294A (en
Inventor
Tarig Sayed Mustafa Arbab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saccharides Science and Tech Ltd
Original Assignee
Saccharides Science and Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0811274A external-priority patent/GB2468629B/en
Application filed by Saccharides Science and Tech Ltd filed Critical Saccharides Science and Tech Ltd
Priority to GB1111470.9A priority Critical patent/GB2479294B/en
Priority claimed from GB0822158A external-priority patent/GB2465814B/en
Publication of GB201111470D0 publication Critical patent/GB201111470D0/en
Publication of GB2479294A publication Critical patent/GB2479294A/en
Application granted granted Critical
Publication of GB2479294B publication Critical patent/GB2479294B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L1/307
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB1111470.9A 2008-06-19 2008-12-04 Method, composition and device for the treatment of enzymes and saccharides disorders Expired - Fee Related GB2479294B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1111470.9A GB2479294B (en) 2008-06-19 2008-12-04 Method, composition and device for the treatment of enzymes and saccharides disorders

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0811274A GB2468629B (en) 2008-06-08 2008-06-19 Method, composition, device for the treatment of amylase malfunctions/inactivity in association with saccharides (mainly polysaccharides) based diseases
GBGB0821501.4A GB0821501D0 (en) 2008-06-08 2008-11-25 Method, composition, and device, for the treatment of enzymes and saccharides disorder
GB1111470.9A GB2479294B (en) 2008-06-19 2008-12-04 Method, composition and device for the treatment of enzymes and saccharides disorders
GB0822158A GB2465814B (en) 2008-06-19 2008-12-04 Method,composition and device for the treatment of enzymes and saccharides disorders

Publications (3)

Publication Number Publication Date
GB201111470D0 GB201111470D0 (en) 2011-08-17
GB2479294A GB2479294A (en) 2011-10-05
GB2479294B true GB2479294B (en) 2012-02-15

Family

ID=44512309

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1111470.9A Expired - Fee Related GB2479294B (en) 2008-06-19 2008-12-04 Method, composition and device for the treatment of enzymes and saccharides disorders

Country Status (1)

Country Link
GB (1) GB2479294B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201614415D0 (en) 2016-08-24 2016-10-05 Pepsis Ltd Enzymes for the treatment of human enterometabolic dysfunction

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003028747A1 (en) * 2001-10-04 2003-04-10 Harris Dennis H Ingestible nerve and circulatory nutritional formulation
US20030211133A1 (en) * 2002-05-10 2003-11-13 Special Ops Nutrition, L.L.C. Ingestible composition for enhancing athletic performance
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
WO2005006890A2 (en) * 2003-07-10 2005-01-27 Forest Carl A Foods, beverages, condiments, spices and salad dressings with specialized supplements

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003028747A1 (en) * 2001-10-04 2003-04-10 Harris Dennis H Ingestible nerve and circulatory nutritional formulation
US20030211133A1 (en) * 2002-05-10 2003-11-13 Special Ops Nutrition, L.L.C. Ingestible composition for enhancing athletic performance
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
WO2005006890A2 (en) * 2003-07-10 2005-01-27 Forest Carl A Foods, beverages, condiments, spices and salad dressings with specialized supplements

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Am J Clin Nutr, Vol 76, 2002, U Schwab et al, "Betaine supplementation decreases plasma homocysteine concentrations...", 961-967 *

Also Published As

Publication number Publication date
GB201111470D0 (en) 2011-08-17
GB2479294A (en) 2011-10-05

Similar Documents

Publication Publication Date Title
SMT202300082T1 (en) Methods and compositions for treating complement-associated disorders
EP2170309A4 (en) Methods and compositions for treating disorders
IL209032A0 (en) Compositions and methods for treating digestive disorders
EP2059282A4 (en) Apparatus, methods and devices for treatment of ocular disorders
ZA200904684B (en) Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
GB2466912B (en) Compositions and methods for treating lysosomal disorders
EP2337535A4 (en) Systems, devices and methods for the treatment of tinnitus
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
PL2356109T3 (en) Compositions and methods for treating alcohol use disorders, pain and other diseases
ZA201006293B (en) Composition and method for seed treatment use
GB0604471D0 (en) Device and method for the treatment of tumours
GB2465814B (en) Method,composition and device for the treatment of enzymes and saccharides disorders
IL211642A0 (en) Method for the treatment of substrates, substrate and treatment device for carrying out said method
IL200570A0 (en) Combination therapy, composition and methods for the treatment of cardiovascular disorders
EP2252608A4 (en) Method for treating pain syndrome and other disorders
GB0821501D0 (en) Method, composition, and device, for the treatment of enzymes and saccharides disorder
PL1982178T3 (en) Methods for the treatment of affective disorders
ZA201003343B (en) Agent for improving sugarcane brix and method of promoting sugarcane ripening using the same
EP2246533A4 (en) Sliding member, and method for treating surface of the sliding member
SI2278962T1 (en) Methods for the treatment of dermatological disorders
GB2479294B (en) Method, composition and device for the treatment of enzymes and saccharides disorders
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
AU2008901355A0 (en) Method for the treatment of mental disorders
AU2008900258A0 (en) Method for the treatment of mental disorders
AU2008902365A0 (en) Methods for treating muscle disorders and improving muscle form

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20171204